These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24477837)

  • 1. Naturalistic follow-up of youths treated for pediatric anxiety disorders.
    Ginsburg GS; Becker EM; Keeton CP; Sakolsky D; Piacentini J; Albano AM; Compton SN; Iyengar S; Sullivan K; Caporino N; Peris T; Birmaher B; Rynn M; March J; Kendall PC
    JAMA Psychiatry; 2014 Mar; 71(3):310-8. PubMed ID: 24477837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results From the Child/Adolescent Anxiety Multimodal Extended Long-Term Study (CAMELS): Primary Anxiety Outcomes.
    Ginsburg GS; Becker-Haimes EM; Keeton C; Kendall PC; Iyengar S; Sakolsky D; Albano AM; Peris T; Compton SN; Piacentini J
    J Am Acad Child Adolesc Psychiatry; 2018 Jul; 57(7):471-480. PubMed ID: 29960692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).
    Piacentini J; Bennett S; Compton SN; Kendall PC; Birmaher B; Albano AM; March J; Sherrill J; Sakolsky D; Ginsburg G; Rynn M; Bergman RL; Gosch E; Waslick B; Iyengar S; McCracken J; Walkup J
    J Am Acad Child Adolesc Psychiatry; 2014 Mar; 53(3):297-310. PubMed ID: 24565357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results from the Child/Adolescent Anxiety Multimodal Longitudinal Study (CAMELS): Functional outcomes.
    Swan AJ; Kendall PC; Olino T; Ginsburg G; Keeton C; Compton S; Piacentini J; Peris T; Sakolsky D; Birmaher B; Albano AM
    J Consult Clin Psychol; 2018 Sep; 86(9):738-750. PubMed ID: 30138013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of treatment improvement on long-term anxiety: Results from CAMS and CAMELS.
    Crane ME; Norris LA; Frank HE; Klugman J; Ginsburg GS; Keeton C; Albano AM; Piacentini J; Peris TS; Compton SN; Sakolsky D; Birmaher B; Kendall PC
    J Consult Clin Psychol; 2021 Feb; 89(2):126-133. PubMed ID: 33705168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS).
    Rabner J; Olino TM; Albano AM; Keeton CP; Sakolsky D; Birmaher B; Piacentini J; Peris TS; Compton SN; Gosch E; Ginsburg GS; Pinney EL; Kendall PC
    J Child Psychol Psychiatry; 2024 Jul; 65(7):910-920. PubMed ID: 38217328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.
    Durham RC; Chambers JA; Power KG; Sharp DM; Macdonald RR; Major KA; Dow MG; Gumley AI
    Health Technol Assess; 2005 Nov; 9(42):1-174. PubMed ID: 16266559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial.
    Compton SN; Peris TS; Almirall D; Birmaher B; Sherrill J; Kendall PC; March JS; Gosch EA; Ginsburg GS; Rynn MA; Piacentini JC; McCracken JT; Keeton CP; Suveg CM; Aschenbrand SG; Sakolsky D; Iyengar S; Walkup JT; Albano AM
    J Consult Clin Psychol; 2014 Apr; 82(2):212-24. PubMed ID: 24417601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS.
    Ginsburg GS; Kendall PC; Sakolsky D; Compton SN; Piacentini J; Albano AM; Walkup JT; Sherrill J; Coffey KA; Rynn MA; Keeton CP; McCracken JT; Bergman L; Iyengar S; Birmaher B; March J
    J Consult Clin Psychol; 2011 Dec; 79(6):806-13. PubMed ID: 22122292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of child-focused anxiety treatments for parents and family functioning.
    Keeton CP; Ginsburg GS; Drake KL; Sakolsky D; Kendall PC; Birmaher B; Albano AM; March JS; Rynn M; Piacentini J; Walkup JT
    Depress Anxiety; 2013 Sep; 30(9):865-72. PubMed ID: 23390005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing Clinical Cutoffs for Response and Remission on the Screen for Child Anxiety Related Emotional Disorders (SCARED).
    Caporino NE; Sakolsky D; Brodman DM; McGuire JF; Piacentini J; Peris TS; Ginsburg GS; Walkup JT; Iyengar S; Kendall PC; Birmaher B
    J Am Acad Child Adolesc Psychiatry; 2017 Aug; 56(8):696-702. PubMed ID: 28735699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial.
    Kelly JM; Jakubovski E; Bloch MH
    J Clin Psychiatry; 2015 Mar; 76(3):267-78. PubMed ID: 25562579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parental psychopathology and treatment outcome for anxious youth: roles of family functioning and caregiver strain.
    Schleider JL; Ginsburg GS; Keeton CP; Weisz JR; Birmaher B; Kendall PC; Piacentini J; Sherrill J; Walkup JT
    J Consult Clin Psychol; 2015 Feb; 83(1):213-24. PubMed ID: 25222799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood and suicidality outcomes 3-11 years following pediatric anxiety disorder treatment.
    Keeton CP; Caporino NE; Kendall PC; Iyengar S; Lee P; Peris T; Sakolsky D; Piacentini J; Compton SN; Albano AM; Birmaher B; Ginsburg GS
    Depress Anxiety; 2019 Oct; 36(10):930-940. PubMed ID: 31356713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating evidence-based assessment into clinical practice for pediatric anxiety disorders.
    McGuire JF; Caporino NE; Palitz SA; Kendall PC; Albano AM; Ginsburg GS; Birmaher B; Walkup JT; Piacentini J
    Depress Anxiety; 2019 Aug; 36(8):744-752. PubMed ID: 31231969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapist-Guided Internet-Delivered Cognitive Behavioral Therapy vs Internet-Delivered Supportive Therapy for Children and Adolescents With Social Anxiety Disorder: A Randomized Clinical Trial.
    Nordh M; Wahlund T; Jolstedt M; Sahlin H; Bjureberg J; Ahlen J; Lalouni M; Salomonsson S; Vigerland S; Lavner M; Öst LG; Lenhard F; Hesser H; Mataix-Cols D; Högström J; Serlachius E
    JAMA Psychiatry; 2021 Jul; 78(7):705-713. PubMed ID: 33978699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of co-occurring depression on treatment for anxiety disorders: analysis of outcomes from a large primary care effectiveness trial.
    Campbell-Sills L; Sherbourne CD; Roy-Byrne P; Craske MG; Sullivan G; Bystritsky A; Lang AJ; Chavira DA; Rose RD; Shaw Welch S; Stein MB
    J Clin Psychiatry; 2012 Dec; 73(12):1509-16. PubMed ID: 23290323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders.
    Ori R; Amos T; Bergman H; Soares-Weiser K; Ipser JC; Stein DJ
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD007803. PubMed ID: 25957940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.